These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2892853)

  • 21. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S; Kim HS; Wood PL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The kappa-opioid receptor from human placenta: hydrodynamic characteristics and evidence for its association with a G protein.
    Porthé G; Francés B; Verrier B; Cros J; Meunier JC
    Life Sci; 1988; 43(6):559-67. PubMed ID: 2841553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Separation of kappa-opioid receptor subtype from frog brain.
    Simon J; Benyhe S; Borsodi A; Szücs M; Wollemann M
    FEBS Lett; 1985 Apr; 183(2):395-7. PubMed ID: 2985433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mu-opioid receptor in the 7315c tumor cell.
    Tocque B; Jacobson AE; Rice KC; Frey EA
    Eur J Pharmacol; 1987 Nov; 143(1):127-30. PubMed ID: 2826184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.
    Tam SW
    Eur J Pharmacol; 1985 Feb; 109(1):33-41. PubMed ID: 2986989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of mu, kappa and delta opioid receptors in the rat brain by isoflurane and enflurane.
    Tejwani GA; Rattan AK; Gudehithlu KP; McDonald JS
    Neuropharmacology; 1991 Jun; 30(6):643-9. PubMed ID: 1656304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Luteinizing hormone-releasing hormone binds to enriched human placental membranes and stimulates in vitro the synthesis of bioactive human chorionic gonadotropin.
    Belisle S; Guevin JF; Bellabarba D; Lehoux JG
    J Clin Endocrinol Metab; 1984 Jul; 59(1):119-26. PubMed ID: 6327754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of rat brain opioid receptors by cannabinoids.
    Vaysse PJ; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
    Kazmi SM; Mishra RK
    Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats.
    Spencer RL; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Jul; 246(1):92-101. PubMed ID: 2839673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.
    Bhargava HN; Das S
    Brain Res; 1986 Mar; 368(2):262-7. PubMed ID: 3008927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of human placental opioid receptors by 3H-ethylketocyclazocine and 3H-naloxone binding.
    Agbas A; Simon J; Avni Oktem H; Varga E; Borsodi A
    Neuropeptides; 1988 Oct; 12(3):171-6. PubMed ID: 2907370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CNS blockade of acoustic stress-induced gastric motor inhibition by kappa-opiate agonists in dogs.
    Gue M; Honde C; Pascaud X; Junien JL; Alvinerie M; Bueno L
    Am J Physiol; 1988 Jun; 254(6 Pt 1):G802-7. PubMed ID: 2897797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of opioid receptors in guinea-pig cerebellum and human placenta.
    Ishizuka Y; Oka T; Kenjo T; Fujii A
    Tokai J Exp Clin Med; 1986 Aug; 11(3):179-84. PubMed ID: 3039693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. U50,488: a kappa-selective agent with poor affinity for mu1 opiate binding sites.
    Clark JA; Pasternak GW
    Neuropharmacology; 1988 Mar; 27(3):331-2. PubMed ID: 2836756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naloxone-inaccessible sigma receptor in rat central nervous system.
    Tam SW
    Proc Natl Acad Sci U S A; 1983 Nov; 80(21):6703-7. PubMed ID: 6314335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.